OKT3 and ganciclovir treatments are possibly related to the presence of Epstein-Barr virus in serum after liver transplantation.
about
Review of Epstein-Barr virus and post-transplant lymphoproliferative disorder post-solid organ transplantation.Challenges and approaches for the development of safer immunomodulatory biologics.Detection of Epstein-Barr virus DNAemia after lung transplantation and its potential relationship with the development of post-transplant complications.Characteristics of Epstein-Barr viraemia in adult liver transplant patients: a retrospective cohort study.
P2860
OKT3 and ganciclovir treatments are possibly related to the presence of Epstein-Barr virus in serum after liver transplantation.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
OKT3 and ganciclovir treatment ...... m after liver transplantation.
@en
OKT3 and ganciclovir treatment ...... m after liver transplantation.
@nl
type
label
OKT3 and ganciclovir treatment ...... m after liver transplantation.
@en
OKT3 and ganciclovir treatment ...... m after liver transplantation.
@nl
prefLabel
OKT3 and ganciclovir treatment ...... m after liver transplantation.
@en
OKT3 and ganciclovir treatment ...... m after liver transplantation.
@nl
P2860
P1476
OKT3 and ganciclovir treatment ...... m after liver transplantation.
@en
P2093
Kerstin I Falk
Lisbeth Barkholt
P2860
P304
P356
10.1111/J.1432-2277.2005.00145.X
P50
P577
2005-07-01T00:00:00Z